The telehealth company announced on Thursday that it would sell a $49 compounded version of Wegovys weight loss pill, but on Saturday announced it would stop
Conclusion Starting GLP-1 therapy is an important step toward better health, and its natural to want guidance that makes the journey feel simple and supported
There are certain conditions where semaglutide should not be used, including decreased kidney function and acute inflammation of the pancreas
Additionally, patients with metabolic dysfunction or insulin resistanceconditions tirzepatide treatsshow higher baseline gallstone prevalence, compounding the effect of rapid weight loss
Staying well hydrated during the early weeks of treatment is one of the simplest ways to protect kidney function
What the Observational Evidence Actually Reports A retrospective cohort study published in The American Journal of Medicine used a global electronic health record database and, after propensity score matching, analysed 9,386 patients who had both systemic lupus erythematosus and type 2 diabetes, stratified by exposure to a GLP-1 receptor agonist
